Globus Medical Inc
GMED- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001237831
In the last 90 days, Globus Medical Inc insiders filed 0 open-market purchases and 2 sales; 601 institutions reported holding it in 13F filings for Q2 2026, worth $9.51B in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $4.41M in total
- 2
- 13F holdersQ2 2026, −4 vs. previous quarter
- 601
- 13F valueReported value at the end of Q2 2026
- $9.51B
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding GMED, Q2 2026
No superinvestor reported holding GMED at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Globus Medical Inc insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 16, 2026 (view filing)4:35 PM ET | Sep 15 | 1 day | Tobin James RDirector | SSaleClass A Common Stock | −30.0K | $74.58 | −$2.24M | −100.0%0 after | |
| Aug 19, 2026 (view filing)5:07 PM ET | Aug 18 | 1 day | Zarrilli Stephen TDirector | SSaleClass A Common Stock | −25.0K | $87.04 | −$2.18M | −100.0%0 after | |
| Jun 9, 2026 (view filing) | Jun 5 | 4 days | Davidar David DDirector | SSaleClass A Common Stock | −25.0K | $80.76 | −$2.02M | −4.7%510.2K after | |
| Feb 27, 2026 (view filing) | Feb 25 | 2 days | Huller KellyEVP, GC, Corporate Secretary | SSaleClass A Common Stock | −20.0K | $94.50 | −$1.89M | −100.0%0 after | 10b5-1 |
| Feb 17, 2026 (view filing) | Feb 12 | 5 days | Huller KellyEVP, GC, Corporate Secretary | SSaleClass A Common Stock | −10.0K | $87.67 | −$876.7K | −100.0%0 after | 10b5-1 |
| Jan 12, 2026 (view filing) | Jan 8 | 4 days | Kline KyleSenior Vice President, CFO | SSaleClass A Common Stock | −3.59K | $101.10 | −$363.4K | −100.0%0 after | 10b5-1 |
| Jan 12, 2026 (view filing) | Jan 8 | 4 days | Norwalk Leslie VDirector | SSaleClass A Common Stock | −2.00K | $101.10 | −$202.2K | −16.1%10.4K after | 10b5-1 |
| Dec 16, 2025 (view filing) | Dec 12 | 4 days | Norwalk Leslie VDirector | SSaleClass A Common Stock | −4.00K | $88.85 | −$355.4K | −24.4%12.4K after | 10b5-1 |
| Nov 28, 2025 (view filing) | Nov 25 | 3 days | Huller KellySVP, GC, Corporate Secretary | SSaleClass A Common Stock | −7.50K | $90.00 | −$675.0K | −100.0%0 after | 10b5-1 |
| Nov 13, 2025 (view filing) | Nov 12 | 1 day | Davidar David DDirector | SSaleClass A Common Stock | −25.0K | $86.00 | −$2.15M | −4.6%516.3K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Globus Medical Inc at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 10,806,724 | $853.8M | 0.01% | +309,310+2.9% | Added |
| Jupiter Topco LLC | 8,200,423 | $647.9M | 0.26% | +8,200,423 | New |
| Vanguard Capital Management LLC | 5,107,532 | $403.5M | 0.01% | +74,800+1.5% | Added |
| Vanguard Portfolio Management LLC | 4,994,385 | $394.6M | 0.02% | +114,926+2.4% | Added |
| Invesco Ltd. | 4,309,771 | $340.5M | 0.03% | −6,883−0.2% | Reduced |
| Kayne Anderson Rudnick Investment Management LLC | 4,279,730 | $338.1M | 1.05% | +4,279,730 | New |
| State Street Corp | 3,714,029 | $293.5M | 0.01% | +123,657+3.4% | Added |
| Sculptor Capital LP | 3,000,000 | $237.0M | 2.45% | −58,000−1.9% | Reduced |
| JPMorgan Chase & Co | 2,743,850 | $230.8M | 0.01% | +148,542+5.7% | Added |
| Alliancebernstein L.P. | 2,380,344 | $205.1M | 0.07% | +629,512+36.0% | Added |